Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

With Chevron's End, LGBTQ+ Healthcare Regs Face New Risk No Photo Available

Hannah Albarazi

The end of Chevron deference is already disrupting regulation meant to protect LGBTQ+ access to healthcare, with three federal judges ... (more story)

Healthcare Cases To Watch: A 2024 Midyear Report No Photo Available

Gianna Ferrarin

Courts across the U.S. this year will oversee key cases to the healthcare industry, from multidistrict litigation over the Change Heal... (more story)

Jarkesy Decision May Hit Key Healthcare Enforcement Tool No Photo Available

Theresa Schliep

Healthcare companies battling civil fines imposed by federal health regulators are already embracing a U.S. Supreme Court decision wea... (more story)